Oestrogen and Parkinson’s Disease
Oestrogen and Parkinson’s Disease
Can Oestrogen Supplements Help Women with Parkinson’s Disease? What the Science Says
Parkinson’s disease (PD) affects both men and women, but
women often notice changes in their symptoms after menopause, when oestrogen
levels drop. This has led many to wonder: could oestrogen supplements help
women with Parkinson’s manage their symptoms or even slow the disease?
Here’s what the latest research tells us—summed up for the
Parkinson’s community.
The Link Between Oestrogen and Parkinson’s
Oestrogen is a hormone best known for its role in women’s
health, but it also has important effects on the brain. Scientists have noticed
that women are less likely to develop Parkinson’s than men, and that risk rises
after menopause. This suggests oestrogen might help protect the brain cells
that are lost in Parkinson’s.
A large meta-analysis pooling results from many studies
found that women who used oestrogen therapy after menopause had a lower risk of
developing Parkinson’s disease compared to those who did not (odds ratio 0.47,
meaning about half the risk)6. Another study found that women who took oestrogen after
menopause were less likely to develop PD than those who didn’t4.
Can Oestrogen Improve Symptoms in Women Who Already Have Parkinson’s?
Some studies suggest oestrogen supplements may help with
symptoms, especially in the early stages of the disease. For example:
- A
study from Columbia University found that women with early PD who had used
oestrogen had less severe symptoms than those who hadn’t, even before
starting standard Parkinson’s medications1.
- A
small clinical trial in postmenopausal women with more advanced PD found
that oestrogen therapy was safe and well-tolerated over eight weeks, with
a trend toward improved movement and daily functioning, though the results
weren’t statistically significant due to the small sample size2.
How Might Oestrogen Help?
Research in both people and animal models suggests oestrogen
may:
- Protect
the brain’s dopamine-producing cells from damage
- Reduce
inflammation in the brain
- Help
the brain adapt and compensate for cell loss35
A recent imaging study showed that women with a longer
lifetime exposure to oestrogen had healthier dopamine systems and less severe
motor symptoms than those with shorter exposure5.
Is Oestrogen Supplementation Safe?
Short-term studies show that oestrogen therapy is generally
safe for postmenopausal women with Parkinson’s, with mild side effects like
breast tenderness or spotting2. However, oestrogen therapy is not risk-free; it can
increase the risk of certain cancers, blood clots, and stroke, so it’s not
suitable for everyone.
The Bottom Line
- Oestrogen
may help protect the brain and reduce the risk or severity of Parkinson’s
in women.
- Some
women with PD and low oestrogen levels may benefit from oestrogen therapy,
especially early in the disease, but more research is needed.
- The
decision to use oestrogen supplements should always be made with your
healthcare team, weighing the potential benefits and risks for your
individual situation.
Key References:
- Currie
LJ, Harrison MB, Trugman JM, et al. Postmenopausal Estrogen Use Affects
Risk for Parkinson Disease. Arch Neurol. 2004;61(6):886–888.4
- Miller
IN, Cronin-Golomb A. Gender differences in Parkinson’s disease: clinical
characteristics and cognition. Mov Disord. 2010;25(16):2695-2703.1
- Liu
R, Huang X, Chen H. Meta-analysis of estrogen replacement therapy for
Alzheimer’s and Parkinson’s diseases in postmenopausal women. Front
Neurosci. 2020;14:157.6
- Jeon
BS, et al. Beneficial effect of estrogen on nigrostriatal dopaminergic
neurons in postmenopausal drug-naïve Parkinson’s disease. Sci Rep.
2019;9:10226.5
- Haaxma
CA, et al. Gender differences in Parkinson’s disease. J Neurol Neurosurg
Psychiatry. 2007;78(8):819-824.2
If you have questions about hormone therapy and Parkinson’s,
talk to your neurologist or Parkinson’s nurse specialist. Every woman’s
situation is unique, and your care team can help you make the best choice for
your health.
Citations:
- https://pubmed.ncbi.nlm.nih.gov/10227628/
- https://pubmed.ncbi.nlm.nih.gov/21824799/
- https://pmc.ncbi.nlm.nih.gov/articles/PMC2048656/
- https://jamanetwork.com/journals/jamaneurology/fullarticle/786007
- https://www.nature.com/articles/s41598-019-47026-6
- https://www.frontiersin.org/journals/neuroscience/articles/10.3389/fnins.2020.00157/full
- https://pmc.ncbi.nlm.nih.gov/articles/PMC9631815/
- https://www.sciencedirect.com/science/article/abs/pii/S1353802011002252
- https://www.news-medical.net/health/Estrogen-as-a-Treatment-for-Parkinsons-Disease.aspx
- https://www.neurology.org/doi/10.1212/WNL.52.7.1417
Comments
Post a Comment